Atlas Capital Advisors LLC Novartis Ag Transaction History

Atlas Capital Advisors LLC

  • $800 Billion
  • Q1 2025

A detailed history of Atlas Capital Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,532 shares of NVS stock, worth $506,994. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,532
Previous 4,532 -0.0%
Holding current value
$506,994
Previous $441 Million 14.56%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$96.78 - $117.18 $367,764 - $445,284
3,800 Added 519.13%
4,532 $441 Million
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $403,294 - $459,382
-3,800 Reduced 83.85%
732 $84.2 Million
Q2 2024

Jul 29, 2024
BUY
$92.57 - $107.37 $351,766 - $408,006
3,800 Added 519.13%
4,532 $482 Million
Q1 2024

Apr 15, 2024
SELL
$95.27 - $108.47 $466,060 - $530,635
-4,892 Reduced 86.98%
732 $70.8 Million
Q4 2023

Feb 15, 2024
BUY
$92.27 - $101.54 $148,001 - $162,870
1,604 Added 39.9%
5,624 $568 Million
Q4 2022

Feb 15, 2023
SELL
$75.55 - $92.52 $12,616 - $15,450
-167 Reduced 3.99%
4,020 $365 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $225,247 - $263,437
-3,019 Reduced 41.9%
4,187 $318 Million
Q2 2022

Aug 16, 2022
SELL
$80.52 - $93.75 $368,942 - $429,562
-4,582 Reduced 38.87%
7,206 $609 Million
Q4 2021

Feb 01, 2022
BUY
$79.7 - $88.13 $216,704 - $239,625
2,719 Added 29.98%
11,788 $1.03 Billion
Q3 2021

Oct 28, 2021
BUY
$81.78 - $95.14 $398,186 - $463,236
4,869 Added 115.93%
9,069 $741,000
Q1 2021

May 10, 2021
SELL
$83.5 - $98.47 $180,610 - $212,990
-2,163 Reduced 33.99%
4,200 $359,000
Q2 2020

Jul 28, 2020
SELL
$80.93 - $91.1 $11,896 - $13,391
-147 Reduced 2.26%
6,363 $555,000
Q1 2020

May 04, 2020
SELL
$70.67 - $99.01 $435,680 - $610,396
-6,165 Reduced 48.64%
6,510 $536,000
Q4 2019

Jan 28, 2020
SELL
$84.35 - $95.37 $85,446 - $96,609
-1,013 Reduced 7.4%
12,675 $1.2 Million
Q3 2019

Nov 01, 2019
BUY
$85.54 - $94.26 $87,165 - $96,050
1,019 Added 8.04%
13,688 $1.19 Million
Q2 2019

Jul 25, 2019
BUY
$75.4 - $92.8 $147,256 - $181,238
1,953 Added 18.23%
12,669 $0
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $325,156 - $371,909
4,317 Added 67.46%
10,716 $0
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $176,710 - $196,765
2,399 Added 59.98%
6,399 $492,000
Q2 2018

Jul 30, 2018
SELL
$64.91 - $73.36 $269,765 - $304,884
-4,156 Reduced 50.96%
4,000 $0
Q1 2018

Apr 18, 2018
BUY
$70.39 - $84.15 $574,100 - $686,327
8,156 New
8,156 $0

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email